BioCentury
ARTICLE | Financial News

Earnings roundup: Baxalta, Alkermes, Alexion, BioMarin

October 30, 2015 12:51 AM UTC

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Baxalta Inc. (NYSE:BXLT), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and Alkermes plc (NASDAQ:ALKS) reported 3Q15 earnings on Thursday.

Alexion reported non-GAAP diluted EPS of $1.16, topping analysts' consensus of $1.01. Its $666.6 million in 3Q15 revenues fell just short of the consensus estimate of $666.9 million. The company raised its 2015 non-GAAP EPS guidance to $4.92-$4.97 from $4.70-$4.80. It expects 2015 revenues to fall at the lower end of its previously announced range of $2.6-$2.62 billion. Alexion shed $1.46 to $175.95 on Thursday. ...